Allergan Officers Selling Shares
- Share via
Eight Allergan Inc. officers registered to sell up to 1.31 million shares of the company’s common stock, according to forms released Thursday by the Securities and Exchange Commission.
The forms indicate an intention to sell restricted stock and allows an individual to sell the shares, but doesn’t indicate when or if the actual sale will occur or has occurred.
Stock of the Irvine eye- and skin-care company has seesawed with the rest of the market, rising to more than $63 a share in February, falling to nearly $45 in March and moving up again. It gained 94 cents a share Thursday to close at $57.34 in New York Stock Exchange trading.
According to the forms, David Pyott, the company’s president, and vice presidents James Mazzo and Lester Kaplan plan to sell 100,000 shares each. Vice presidents David Fellows, Francis Tunney, Jacqueline Schaivo and F. Michael Ball planned to sell 200,000 shares each. Vice President George Lasezkay planned to sell as many as 210,000 shares.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
